Drug Consumption in Current Year (Period 201901
Total Page:16
File Type:pdf, Size:1020Kb
Page 1 Drug consumption in current year (Period 202001 - 202012) Wholesale ATC code Subgroup or chemical substance DDD/1000 inhab./day Hospital % Change % price/1000 € Hospital % Change % A ALIMENTARY TRACT AND METABOLISM 323,80 3 4 321 589 7 4 A01 STOMATOLOGICAL PREPARATIONS 14,28 4 12 2 090 9 8 A01A STOMATOLOGICAL PREPARATIONS 14,28 4 12 2 090 9 8 A01AA Caries prophylactic agents 11,90 3 14 663 8 9 A01AA01 sodium fluoride 11,90 3 14 610 8 10 A01AA03 olaflur - - - 53 1 -2 A01AB Antiinfectives for local oral treatment 2,36 8 2 1 266 10 15 A01AB03 chlorhexidine 2,02 6 -3 930 6 5 A01AB11 various 0,33 21 57 335 21 55 A01AB22 doxycycline - - - 0 - -100 A01AC Corticosteroids for local oral treatment - - - 113 1 -26 A01AC01 triamcinolone - - - 113 1 -26 A01AD Other agents for local oral treatment 0,02 0 -28 49 0 -32 A01AD02 benzydamine 0,02 0 -28 49 0 -32 A02 DRUGS FOR ACID RELATED DISORDERS 73,05 3 3 30 885 4 -5 A02A ANTACIDS 2,23 1 1 3 681 1 3 A02AA Magnesium compounds 0,07 22 -7 141 22 -7 A02AA04 magnesium hydroxide 0,07 22 -7 141 22 -7 A02AD Combinations and complexes of aluminium, 2,17 0 1 3 539 0 4 calcium and magnesium compounds A02AD01 ordinary salt combinations 2,17 0 1 3 539 0 4 A02B DRUGS FOR PEPTIC ULCER AND 70,82 3 3 27 205 5 -7 GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) A02BA H2-receptor antagonists 0,17 7 -77 551 10 -29 A02BA02 ranitidine 0,00 1 -100 1 1 -100 A02BA03 famotidine 0,16 7 48 550 10 43 A02BB Prostaglandins 0,04 62 55 80 62 55 A02BB01 misoprostol 0,04 62 55 80 62 55 A02BC Proton pump inhibitors 69,26 3 4 23 531 4 -8 A02BC01 omeprazole 8,62 2 -2 2 406 3 -5 A02BC02 pantoprazole 37,89 4 6 8 047 8 -15 A02BC03 lansoprazole 5,47 1 -3 1 205 1 -42 Page 2 Drug consumption in current year (Period 202001 - 202012) Wholesale ATC code Subgroup or chemical substance DDD/1000 inhab./day Hospital % Change % price/1000 € Hospital % Change % A02BC04 rabeprazole 1,59 1 8 922 1 8 A02BC05 esomeprazole 15,68 2 5 10 950 3 3 A02BD Combinations for eradication of Helicobacter pylori 0,02 0 -35 218 0 -28 A02BD03 lansoprazole, metronidazole and amoxicillin 0,00 0 -69 23 0 -69 A02BD07 lansoprazole, amoxicillin and clarithromycin 0,02 0 -14 196 0 -14 A02BX Other drugs for peptic ulcer and 1,33 8 11 2 825 7 17 gastro-oesophageal reflux disease (GORD) A02BX02 sucralfate 0,35 22 20 574 21 21 A02BX13 alginic acid 0,98 3 7 2 251 3 16 A03 DRUGS FOR FUNCTIONAL 2,67 10 -2 5 455 46 -7 GASTROINTESTINAL DISORDERS A03A DRUGS FOR FUNCTIONAL 1,17 7 -5 1 895 19 1 GASTROINTESTINAL DISORDERS A03AB Synthetic anticholinergics, quaternary ammonium 0,05 87 -3 372 87 -3 compounds A03AB02 glycopyrronium bromide 0,05 87 -3 372 87 -3 A03AX Other drugs for functional gastrointestinal disorders 1,12 3 -5 1 523 2 2 A03AX13 silicones 1,12 3 -5 1 389 3 -6 A03AX15 menthae piperitae aetheroleum - - - 135 0 640 A03B BELLADONNA AND DERIVATIVES, PLAIN 0,04 93 -34 344 93 -47 A03BA Belladonna alkaloids, tertiary amines 0,04 93 -36 285 92 -49 A03BA01 atropine 0,04 93 -36 285 92 -49 A03BB Belladonna alkaloids semisynthetic, quaternary 0,00 97 0 59 96 -32 ammonium compounds A03BB01 butylscopolamine 0,00 97 0 59 96 -32 A03C ANTISPASMODICS IN COMBINATION WITH 0,18 1 -11 196 1 -12 PSYCHOLEPTICS A03CA Synthetic anticholinergic agents in combination 0,18 1 -11 196 1 -12 with psycholeptics A03CA02 clidinium and psycholeptics 0,18 1 -11 196 1 -12 A03D ANTISPASMODICS IN COMBINATION WITH 0,26 11 13 2 599 64 -4 ANALGESICS A03DA Synthetic anticholinergic agents in combination 0,26 11 13 2 599 64 -4 with analgesics Page 3 Drug consumption in current year (Period 202001 - 202012) Wholesale ATC code Subgroup or chemical substance DDD/1000 inhab./day Hospital % Change % price/1000 € Hospital % Change % A03DA02 pitofenone and analgesics 0,26 11 13 2 599 64 -4 A03F PROPULSIVES 1,01 11 1 421 35 9 A03FA Propulsives 1,01 11 1 421 35 9 A03FA01 metoclopramide 1,01 11 1 421 35 9 A04 ANTIEMETICS AND ANTINAUSEANTS 0,30 43 2 4 860 48 16 A04A ANTIEMETICS AND ANTINAUSEANTS 0,30 43 2 4 860 48 16 A04AA Serotonin (5HT3) antagonists 0,24 47 2 4 128 48 23 A04AA01 ondansetron 0,16 47 6 1 864 65 86 A04AA02 granisetron 0,06 43 -4 851 41 -2 A04AA05 palonosetron 0,01 100 -16 257 99 -13 A04AA55 palonosetron, combinations 0,01 15 7 1 157 15 -2 A04AD Other antiemetics 0,06 28 2 731 49 -14 A04AD01 scopolamine 0,06 26 5 373 26 24 A04AD12 aprepitant 0,01 50 -13 359 73 -32 A04AD14 rolapitant - - -100 0 - -100 A05 BILE AND LIVER THERAPY 0,92 3 -2 1 414 3 -37 A05A BILE THERAPY 0,92 3 -2 1 414 3 -37 A05AA Bile acids and derivatives 0,92 3 -2 1 414 3 -37 A05AA02 ursodeoxycholic acid 0,92 3 -2 1 342 3 -39 A05AA04 obeticholic acid 0,00 4 108 72 4 108 A06 DRUGS FOR CONSTIPATION 51,34 8 7 29 145 11 7 A06A DRUGS FOR CONSTIPATION 51,34 8 7 29 145 11 7 A06AB Contact laxatives 6,31 5 2 3 740 7 -1 A06AB02 bisacodyl 0,71 2 -22 265 2 -27 A06AB06 senna glycosides 0,13 0 -14 52 0 -13 A06AB08 sodium picosulfate 5,48 6 7 2 819 4 5 A06AB56 senna glycosides, combinations - - - 163 0 -3 A06AB58 sodium picosulfate, combinations 0,00 30 -12 441 31 -13 A06AC Bulk-forming laxatives 12,01 1 12 5 859 2 11 A06AC01 ispaghula (psylla seeds) 11,43 1 13 5 629 2 11 A06AC51 ispaghula, combinations 0,59 1 -3 230 1 -3 A06AD Osmotically acting laxatives 31,51 11 7 16 138 12 9 A06AD11 lactulose 13,23 9 -1 2 630 9 -3 A06AD15 macrogol 17,20 13 16 11 751 12 15 Page 4 Drug consumption in current year (Period 202001 - 202012) Wholesale ATC code Subgroup or chemical substance DDD/1000 inhab./day Hospital % Change % price/1000 € Hospital % Change % A06AD17 sodium phosphate - - - 41 18 -25 A06AD65 macrogol, combinations 1,08 3 -13 1 716 21 -3 A06AG Enemas 1,31 10 -4 2 419 17 -4 A06AG02 bisacodyl 0,24 33 -2 414 32 -2 A06AG10 docusate sodium, incl. combinations 0,06 49 -7 555 45 -6 A06AG11 laurilsulfate, incl. combinations 1,01 3 -4 1 450 2 -4 A06AH Peripheral opioid receptor antagonists 0,13 28 22 756 39 21 A06AH01 methylnaltrexone bromide 0,00 97 12 133 97 12 A06AH03 naloxegol 0,13 26 22 624 26 24 A06AX Other drugs for constipation 0,06 9 36 233 11 29 A06AX04 linaclotide 0,03 1 71 111 1 69 A06AX05 prucalopride 0,02 20 7 122 20 7 A07 ANTIDIARRHEALS, INTESTINAL 14,08 2 0 29 004 5 -2 ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS A07A INTESTINAL ANTIINFECTIVES 0,17 21 21 2 666 34 11 A07AA Antibiotics 0,17 21 21 2 666 34 11 A07AA02 nystatin 0,07 18 6 679 18 2 A07AA09 vancomycin 0,01 53 0 687 53 -2 A07AA11 rifaximin 0,09 20 40 1 026 20 40 A07AA12 fidaxomicin 0,00 73 -6 274 73 -6 A07B INTESTINAL ADSORBENTS 0,14 55 9 668 54 -1 A07BA Charcoal preparations 0,14 55 9 668 54 -1 A07BA01 medicinal charcoal 0,14 55 9 668 54 -1 A07C ELECTROLYTES WITH CARBOHYDRATES 0,01 5 -40 138 5 -40 A07CA Oral rehydration salt formulations 0,01 5 -40 138 5 -40 A07D ANTIPROPULSIVES 1,20 2 -12 3 788 1 -14 A07DA Antipropulsives 1,20 2 -12 3 788 1 -14 A07DA03 loperamide 1,20 2 -12 2 962 1 -13 A07DA06 eluxadoline - - -100 0 - -100 A07DA53 loperamide, combinations - - - 825 0 -19 A07E INTESTINAL ANTIINFLAMMATORY AGENTS 11,75 1 5 18 973 1 6 A07EA Corticosteroids acting locally 0,85 3 7 1 976 3 8 A07EA06 budesonide 0,85 3 7 1 976 3 8 A07EC Aminosalicylic acid and similar agents 10,90 1 5 16 997 1 5 Page 5 Drug consumption in current year (Period 202001 - 202012) Wholesale ATC code Subgroup or chemical substance DDD/1000 inhab./day Hospital % Change % price/1000 € Hospital % Change % A07EC01 sulfasalazine 3,26 1 2 2 937 1 2 A07EC02 mesalazine 7,63 1 6 14 046 1 6 A07EC03 olsalazine 0,01 3 -31 14 3 -31 A07F ANTIDIARRHEAL MICROORGANISMS 0,82 4 -31 2 473 4 -31 A07FA Antidiarrheal microorganisms 0,82 4 -31 2 473 4 -31 A07FA01 lactic acid producing organisms - - -100 0 - -100 A07FA02 saccharomyces boulardii 0,82 4 -31 2 473 4 -31 A07X OTHER ANTIDIARRHEALS - - - 299 7 -34 A07XA Other antidiarrheals - - - 299 7 -34 A07XA04 racecadotril - - - 299 7 -34 A08 ANTIOBESITY PREPARATIONS, EXCL. DIET 0,07 0 -15 602 0 -6 PRODUCTS A08A ANTIOBESITY PREPARATIONS, EXCL. DIET 0,07 0 -15 602 0 -6 PRODUCTS A08AA Centrally acting antiobesity products - - - 334 0 -6 A08AA62 bupropion and naltrexone - - - 334 0 -6 A08AB Peripherally acting antiobesity products 0,07 0 -15 268 0 -5 A08AB01 orlistat 0,07 0 -15 268 0 -5 A09 DIGESTIVES, INCL. ENZYMES 1,86 4 0 3 146 4 -2 A09A DIGESTIVES, INCL.